MetLife Inc (NYSE:MET)
The intrinsic value of one MET stock under the Base Case scenario is 93.68 USD. Compared to the current market price of 63.3 USD, MetLife Inc is Undervalued by 32%.
The Intrinsic Value is calculated as the average of the two valuation methods:
MET Price Targets
Price Targets made by Wall Street
12-month price targets for MET stock made by Wall Street professionals. The average price target is 76.7 USD with a low forecast of 68.68 USD and a high forecast of 84 USD.
MET Insider Trading
Buy and sell transactions by insiders
During the last 3 months MetLife Inc insiders have not bought any shares, and have not sold any shares. The last transaction was made on Feb 8, 2022 by Steven J Goulart, who sold 4M USD worth of MET shares.
MetLife, Inc. provides insurance and financial services to individual and institutional customers. The company is headquartered in New York City, New York and currently employs 43,000 full-time employees. The company went IPO on 2000-04-05. The firm's segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. The U.S. segment is organized into two businesses, such as Group Benefits, and Retirement and Income Solutions (RIS). The Asia segment offers products, including life insurance; accident and health insurance, and retirement and savings products. The Latin America segment offers government employees life, medical insurance, as well as retirement and savings, and other products, and periodically submits bids to do so. The EMEA segment offers products, including life insurance, accident and health insurance, retirement and savings products, and credit insurance. The MetLife Holdings segment offers variable, universal, term and whole life insurance, variable, fixed and index-linked annuities, and long-term care insurance.
MET Stock FAQ
The intrinsic value of one MET stock under the Base Case scenario is 93.68 USD.
Compared to the current market price of 63.3 USD, MetLife Inc is Undervalued by 32%.